The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Acceleron Pharma Inc. | COM | 00434H108 | 10,272 | 235,868 | SH | SOLE | 235,868 | 0 | 0 | ||
Achaogen, Inc. | COM | 004449104 | 3,524 | 2,864,664 | SH | SOLE | 2,864,664 | 0 | 0 | ||
Aclaris Therapeutics, Inc. | COM | 00461U105 | 1,963 | 265,694 | SH | SOLE | 265,694 | 0 | 0 | ||
Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 70,412 | 1,950,477 | SH | SOLE | 1,950,477 | 0 | 0 | ||
Aimmune Therapeutics, Inc. | COM | 00900T107 | 16,979 | 709,822 | SH | SOLE | 709,822 | 0 | 0 | ||
Alder BioPharmaceuticals, Inc. | COM | 014339105 | 30,157 | 2,942,130 | SH | SOLE | 2,942,130 | 0 | 0 | ||
Arcus Biosciences, Inc. | COM | 03969F109 | 21,851 | 2,028,876 | SH | SOLE | 2,028,876 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 12,786 | 204,088 | SH | SOLE | 204,088 | 0 | 0 | ||
Audentes Therapeutics, Inc. | COM | 05070R104 | 6,723 | 315,331 | SH | SOLE | 315,331 | 0 | 0 | ||
BioDelivery Sciences International, Inc. | COM | 09060J106 | 2,330 | 629,656 | SH | SOLE | 629,656 | 0 | 0 | ||
Biohaven Pharmaceutical Holding Company Ltd. | COM | G11196105 | 3,909 | 105,706 | SH | SOLE | 105,706 | 0 | 0 | ||
Blueprint Medicines Corporation | COM | 09627Y109 | 25,213 | 467,682 | SH | SOLE | 467,682 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | COM | 23257D103 | 12,490 | 1,587,101 | SH | SOLE | 1,587,101 | 0 | 0 | ||
Epizyme, Inc. | COM | 29428V104 | 6,149 | 998,215 | SH | SOLE | 998,215 | 0 | 0 | ||
Immunomedics, Inc. | COM | 452907108 | 38,529 | 2,700,000 | SH | SOLE | 2,700,000 | 0 | 0 | ||
Myokardia, Inc. | COM | 62857M105 | 17,660 | 361,441 | SH | SOLE | 361,441 | 0 | 0 | ||
Natera, Inc. | COM | 632307104 | 3,521 | 252,255 | SH | SOLE | 252,255 | 0 | 0 | ||
Replimune Group, Inc. | COM | 76029N106 | 7,797 | 779,656 | SH | SOLE | 779,656 | 0 | 0 | ||
Solid Biosciences Inc. | COM | 83422E105 | 2,652 | 98,942 | SH | SOLE | 98,942 | 0 | 0 | ||
Tocagen, Inc. | COM | 888846102 | 5,461 | 665,219 | SH | SOLE | 665,219 | 0 | 0 | ||
Verona Pharma Plc | SPONSORED ADS | 925050106 | 1,994 | 206,663 | SH | SOLE | 206,663 | 0 | 0 | ||
WAVE Life Sciences Ltd. | SHS | Y95308105 | 2,102 | 50,000 | SH | SOLE | 50,000 | 0 | 0 |